Guangzhou Kingmed Diagnostics Group Co., Ltd. (SHA:603882)

Market Cap	10.84B -23.8%
Revenue (ttm)	5.91B -13.2%
Net Income	-102.67M
EPS	-0.22
Shares Out	463.26M
PE Ratio	n/a
Forward PE	30.80
Dividend	0.88 (3.66%)
Ex-Dividend Date	Feb 5, 2026

Volume	4,581,137
Open	23.68
Previous Close	24.02
Day's Range	23.19 - 24.12
52-Week Range	23.24 - 40.68
Beta	0.45
Analysts	Buy
Price Target	30.49 (+30.24%)
Earnings Date	Aug 26, 2026

About SHA:603882

Guangzhou Kingmed Diagnostics Group Co., Ltd. provides medical diagnosis services in China. It also provides health check-up, cold chain logistics, and other services. Guangzhou Kingmed Diagnostics Group Co., Ltd. was founded in 2006 and is headquartered in Guangzhou, China.

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 2006
• Employees: 9,529
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 603882

Financial Performance

In 2025, SHA:603882's revenue was 6.03 billion, a decrease of -16.12% compared to the previous year's 7.19 billion. Losses were -173.24 million, -54.56% less than in 2024.

Analyst Summary

According to 8 analysts, the average rating for 603882 stock is "Buy." The 12-month stock price target is ¥30.49, which is an increase of 30.24% from the latest price.

Price Target

¥30.49

(30.24% upside)

Analyst Consensus: Buy